Follow-on offering Completed
AbCellera Biologics equity raising
US$200m raised
NASDAQ: ABCL
Advisers
AbCellera Biologics
Issuer
- Legal adviser
Lead managers
Not disclosed
- Issuer
- AbCellera Biologics
- Issuer based in
- Canada
- Completed
- 24 Aug 2026
- Sector
- Biotech
- Tags
- Biotech, Drug Development
Similar deals
- Sensei Biotherapeutics placement Feb 2026 · US$200m · Biotech
- Silence Therapeutics placement Aug 2026 · US$201m · Biotech
- Agomab Therapeutics NV IPO Feb 2026 · US$200m · Biotech
- Processa Pharmaceuticals placement Jul 2026 · US$200m · Biotech
- Apnimed IPO Jul 2026 · US$192m · Biotech
Sources
- 24 Aug 2026 Goodwin Advises AbCellera Biologics on $200 Million Public Offering goodwinlaw.com
